DR. CHAD A HARSWICK MD
Prescription History 1396734521
Family Medicine in Ames, IA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. CHAD A HARSWICK MD, an active Family Medicine specialist practicing in Ames, IA. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 137 documented patient claims. Among these therapy options, the most frequently utilized medication is Doxycycline Hyclate, which accounts for 44 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IA PrescribersVs. IA Avg |
|---|---|---|---|
| Doxycycline Hyclate | 44 | $14.02▼ below IA avg | ▲ More than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2023, this provider wrote 44 Medicare prescriptions for Doxycycline Hyclate, about 1.8 times the volume of the typical Iowa prescriber of this medication (24). Medicare paid an average of $14.02 per fill, versus $28.54 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IA average for this medication. 44 30-Day Fills standardized to 30-day supplies 362 Days of Medication total across all patients in 2023 | |||
| Prednisone | 37 | $2.14▼ below IA avg | ≈ Typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 37 Medicare prescriptions for Prednisone, about 80% of the volume of the typical Iowa prescriber of this medication (46). Medicare paid an average of $2.14 per fill, versus $5.62 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IA average for this medication. 37 30-Day Fills standardized to 30-day supplies 197 Days of Medication total across all patients in 2023 | |||
| Cephalexin | 24 | $5.50▼ below IA avg | ≈ Typical |
About Cephalexin: This medication is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. In 2023, this provider wrote 24 Medicare prescriptions for Cephalexin, about 80% of the volume of the typical Iowa prescriber of this medication (30). Medicare paid an average of $5.50 per fill, versus $7.80 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IA average for this medication. 24 30-Day Fills standardized to 30-day supplies 161 Days of Medication total across all patients in 2023 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $10.46▼ below IA avg | ▼ Less than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate. In 2023, this provider wrote 16 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 73% of the volume of the typical Iowa prescriber of this medication (22). Medicare paid an average of $10.46 per fill, versus $13.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IA average for this medication. 16 30-Day Fills standardized to 30-day supplies 137 Days of Medication total across all patients in 2023 | |||
| Paxlovid (Eua)Nirmatrelvir/Ritonavir | 16 | $8.90▼ below IA avg | ≈ Typical |
About Paxlovid (Eua): The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾ The product is also approved to be used in Canada to treat COVID-19. It is used by people who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with nirmatrelvir and ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases (boosts) the levels of nirmatrelvir. This helps nirmatrelvir work better. More information about nirmatrelvir and ritonavir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use and from the Health Canada Patient Medication Information sheet. There is limited information about how safe and effective the combination of nirmatrelvir and ritonavir is for treating COVID-19. Study results show that nirmatrelvir and ritonavir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of nirmatrelvir and ritonavir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions. In 2023, this provider wrote 16 Medicare prescriptions for Paxlovid (Eua), about 80% of the volume of the typical Iowa prescriber of this medication (20). Medicare paid an average of $8.90 per fill, versus $10.15 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IA average for this medication. 16 30-Day Fills standardized to 30-day supplies 80 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. CHAD A HARSWICK MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family Medicine prescribing approach at this Ames, IA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
